Abnormal uterine bleeding as a presentation of metastatic breast disease in a patient with advanced breast cancer on tamoxifen therapy

By Famoriyo Akin  

Archives of Gynecology and Obstetrics, Vol. 270, Iss. 3, 2004-11 ,pp. : 192-193

Springer Publishing Company

Access to resources Recommend Favorite

Abnormal uterine bleeding as a presenting sign of metastases to the uterine corpus, cervix and vagina in a breast cancer patient on tamoxifen therapy

By Piura B.   Yanai-Inbar I.   Rabinovich A.   Zalmanov S.   Goldstein J.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 83, Iss. 1, 1999-03 ,pp. : 57-61

Elsevier

Access to resources Recommend Favorite

Carcinosarcoma, endometrial intraepithelial carcinoma and endometriosis after tamoxifen therapy in breast cancer

By Friedrich M.   Villena-Heinsen C.   Mink D.   Bonkhoff H.   Schmidt W.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 82, Iss. 1, 1999-01 ,pp. : 85-87

Elsevier

Access to resources Recommend Favorite

Uterine metastasis of lobular breast cancer during adjuvant letrozole therapy

By Komeda S.  

Journal of Obstetrics & Gynaecology, Vol. 33, Iss. 1, 2013-01 ,pp. : 99-101

Informa Healthcare

Access to resources Recommend Favorite

Endometrial mixed mullerian tumor with heterologous elements following tamoxifen therapy for breast cancer: a case report and literature review

By Kaleli S.   Calay Z.   Altinok T.   Kosebay D.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 101, Iss. 2, 2002-03 ,pp. : 204-208

Elsevier

Access to resources Recommend Favorite